Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Capital Surplus	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss), net	Treasury Stock
Balance Beginning at Dec. 31, 2024	$ 2,039,514	$ 39	$ 160,052	$ 2,418,149	$ (493,529)	$ (10,266)	$ (34,931)
Net Income (Loss)	86,577				86,577
Stock-based compensation expense	3,889			3,889
Stock-based compensation distributed	(885)		287	(287)			(885)
Stock issued for incentive compensation	2,503		119	2,384
Common stock and Series B Preferred Stock dividends declared	(5,023)				(5,023)
Common stock issued for 401(k) match	2,605		121	2,484
Common stock issued to directors	1,034		41	993
Common stock issued under ATM Program	174,132		7,252	166,880
Other comprehensive loss	5,687					5,687
Balance Ending at Jun. 30, 2025	2,310,033	39	167,872	2,594,492	(411,975)	(4,579)	(35,816)
Balance Beginning at Mar. 31, 2025	2,073,967	39	160,228	2,423,631	(467,168)	(7,832)	(34,931)
Net Income (Loss)	57,705				57,705
Stock-based compensation expense	1,953			1,953
Stock-based compensation distributed	(885)		287	(287)			(885)
Common stock and Series B Preferred Stock dividends declared	(2,512)				(2,512)
Common stock issued for 401(k) match	1,386		64	1,322
Common stock issued to directors	1,034		41	993
Common stock issued under ATM Program	174,132		7,252	166,880
Other comprehensive loss	3,253					3,253
Balance Ending at Jun. 30, 2025	2,310,033	39	167,872	2,594,492	(411,975)	(4,579)	(35,816)
Balance Beginning at Dec. 31, 2025	2,591,646	39	169,689	2,643,211	(182,143)	(3,334)	(35,816)
Net Income (Loss)	98,848				98,848
Stock-based compensation expense	4,699			4,699
Stock-based compensation distributed	(4,528)		384	(384)			(4,528)
Common stock issued for warrant conversion	63	(1)	4	60
Common stock and Series B Preferred Stock dividends declared	(5,298)				(5,298)
Common stock issued for 401(k) match	1,313		16	1,297
Common stock issued to directors	1,382		22	1,360
Other comprehensive loss	10,301					(10,301)
Balance Ending at Jun. 30, 2026	2,677,824	38	170,115	2,650,243	(88,593)	(13,635)	(40,344)
Balance Beginning at Mar. 31, 2026	2,570,813	39	169,779	2,647,282	(203,819)	(5,491)	(36,977)
Net Income (Loss)	117,876				117,876
Stock-based compensation expense	1,914			1,914
Stock-based compensation distributed	(3,367)		312	(312)			(3,367)
Common stock issued for preferred stock conversion		(1)	2	(1)
Common stock and Series B Preferred Stock dividends declared	(2,650)				(2,650)
Common stock issued to directors	1,382		22	1,360
Other comprehensive loss	(8,144)					(8,144)
Balance Ending at Jun. 30, 2026	$ 2,677,824	$ 38	$ 170,115	$ 2,650,243	$ (88,593)	$ (13,635)	$ (40,344)